CClinicalTrials.gg
Not yet recruitingNCT06991582Updated May 28, 2025

Clinical Assessment of Injectable Composite Versus Packable Composite in Treatment of Carious Primary Anterior Teeth

A Phase 2 interventional study of Injectable composite resin restoration and packable composite in Carious Primary and Carious Anteriors, sponsored by Cairo University. Not yet recruiting at 1 site in Egypt. Per ClinicalTrials.gov, last updated 2025-05-28.

Sponsored by Cairo University · Phase 2, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Feb 2026, 7 months ago, but the record still lists the study as not yet recruiting.
Phase
Phase 2
Study type
Interventional
Enrollment
16
Allocation
Randomized
Sex
All
01

Study summary

The aim of this study is to evaluate the clinical success of injectable composite versus packable composite in restoration of primary anteriors.

02

Conditions studied

  • Carious Primary
  • Carious Anteriors
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,780 studies on the registry; 1,427 are open to participants now.

Of its 36 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children with caries in primary anterior teeth.
  • Caries involving class III, IV, V or multisurface caries
  • Restorable anterior teeth
  • Pre operative Radiograph showing at least half of the root is not resorbed).

Exclusion criteria

Exclusion Criteria:

  • Badly decayed non restorable anterior teeth
  • Signs and symptoms of root resorption (more than half the root is resorbed)
  • Presence of bony resorption
  • Presence of pathological root resorption
  • Tooth Mobility
05

Study design

Phase
Phase 2
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    Injectable composite

    Injectable composite Beautifil flow Plus X (Shofu INC., Koyoto, Japan)

    Biological: Injectable composite resin restoration

  • Active comparator
    Packable Composite

    Packable Composite Beautifil II (Shofu INC., Koyoto, Japan)

    Biological: packable composite

Interventions

  • BiologicalInjectable composite resin restoration

    Injectable composite Beautifil flow Plus X (Shofu INC., Koyoto, Japan)

  • Biologicalpackable composite

    Packable Composite Beautifil II (Shofu INC., Koyoto, Japan)

06

What researchers measure

Primary outcomes

  1. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Marginal integrity Measuring Device: Explorer Measuring unit: Alpha (A) There is no visible evidence of ditching along the margin of the restoration. Bravo (B) There is visible evidence of ditching along the margin of the restoration, it is not extending to the dentino-enamel junction. Charlie (C) There is dentin or base is exposed along the margin of the restoration. Delta (D) The restoration is mobile, fractured, or missing.

    Time frame: through study completion, on average of 1 year

  2. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Color Match Measuring Device: Visual Inspection Measuring unit: Alpha (A) The restoration appears to match the shade and translucency of adjacent tooth tissues. Bravo (B)The restoration does not match the shade and translucency of adjacent tooth tissues, but the mismatch is within the normal range of tooth shades. Charlie (C)The restoration does not match the shade and translucency of the adjacent tooth structure, and the mismatch is outside the normal range of tooth shades and translucency

    Time frame: through study completion, on average of 1 year

  3. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Cavo surface marginal discoloration Measuring Device: Visual Inspection Measuring unit: Alpha (A) There is no visual evidence of marginal discoloration different from the color of the restorative material and from the color of the adjacent tooth structure. Bravo (B) There is visual evidence of marginal discoloration at the junction of the tooth structure and the restoration, but the discoloration has not penetrated along the restoration in a pulpal direction. Charlie (C) There is visual evidence of marginal discoloration at the junction of the tooth structure and the restoration that has penetrated along the restoration in a pulpal direction.

    Time frame: through study completion, on average of 1 year

  4. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Secondary Caries Measuring Device: Visual Inspection Measuring unit: Alpha (A) The restoration is a continuation of existing anatomic form adjacent to the restoration. Bravo (B) There is visual evidence of dark keep discoloration adjacent to the restoration (but not directly associated with cavosurface margins)

    Time frame: through study completion, on average of 1 year

  5. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Anatomic Contour Measuring Device: Visual Inspection and Explorer Measuring unit: Alpha (A) Visual inspection and explorer The restoration is a continuation of existing anatomic form or is slightly flattened. It may be overcontoured. When the side of the explorer is placed tangentially across the restoration, it does not touch two opposing cavosurface line angles at the same time. Bravo (B) A surface concavity is evident. When the side of the explorer is placed tangentially across the restoration, it does not touch two opposing cavosurface line angles at the same time, but the dentin or base is not exposed. Charlie (C) There is a loss of restorative substance such that a surface concavity is evident and the base and/or dentin is exposed.

    Time frame: through study completion, on average of 1 year

  6. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Surface Texture Measuring Device: Explorer Measuring unit: Alpha (A) Explorer Surface texture similar to polished enamel as determined by means of a sharp explorer. Bravo (B) Explorer Surface texture gritty or similar to a surface subjects to a white stone or similar to a composite containing supramicron-sized particles. Charlie (C) Explorer Surface pitting is sufficiently coarse to inhibit the continuous movement of an explorer across the surface.

    Time frame: through study completion, on average of 1 year

  7. Direct Clinical Assessment of Restoration

    Modified United States Public Health Service (USPHS) Ryge Criteria Outcome name: Gross Fracture Measuring Device: Visual Inspection Measuring unit: Alpha (A) Restoration is intact and fully retained. Bravo (B) Restoration is partially retained with some portion of the restoration still intact. Charlie (C) Restoration is completely missing.

    Time frame: through study completion, on average of 1 year

Secondary outcomes

  1. Parents' patient Satisfaction

    Measuring Device: Questionnaire Measuring unit: Binary (yes or No)

    Time frame: immediately after the intervention/procedure

  2. Chair side time

    Measuring Device: Stopwatch Measuring unit: Minutes

    Time frame: immediately after the intervention/procedure

  3. Plaque accumulation

    Measuring Device: Plaque index Score by Probe Measuring unit: 0 : No plaque 1. : A film of plaque adhering to the free gingival margin and adjacent area of the tooth. The plaque may be seen in situ only by using the probe on the tooth surface. 2. : Moderate accumulation of soft deposits within the gingival pocket, or the tooth and gingival margin which can be seen with the naked eye. 3. : Abundance of soft matter within the gingival pocket and/or on the tooth and gingival margin.

    Time frame: through study completion, on average of 1 year

07

Study locations

1 site
  • Pediatric Dentistry Department, Faculty of Dentistry, Cairo University
    Cairo, Egypt
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 28, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06991582
Lead sponsor
Cairo University
Responsible party
Bassant Mohamed Elmesbahy (Principal investigator, Cairo University) — Principal investigator
First posted
May 28, 2025
Start date
May 28, 2025 (estimated)
Primary completion
Feb 28, 2026 (estimated)
Completion
Mar 30, 2026 (estimated)
Last update
May 28, 2025

Study contacts

Bassant Mohamed ElMesbahy
Contact
bassant.elmesbahy@dentistry.cu.edu.eg
+201127132944

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion